gabexate has been researched along with Epistaxis in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Epistaxis: Bleeding from the nose.
| Excerpt | Relevance | Reference |
|---|---|---|
| "He was diagnosed as metastatic bone cancer with disseminated intravascular coagulation (DIC)." | 1.28 | Disseminated carcinomatosis of bone marrow from submucosal carcinoma in adenoma of the rectum. ( Andachi, H; Shimizu, H; Yokoo, S; Yoshioka, K, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshioka, K | 1 |
| Shimizu, H | 1 |
| Yokoo, S | 1 |
| Andachi, H | 1 |
1 other study available for gabexate and Epistaxis
| Article | Year |
|---|---|
Disseminated carcinomatosis of bone marrow from submucosal carcinoma in adenoma of the rectum.
Topics: Adenoma; Anemia, Hemolytic; Antithrombin III; Bone Neoplasms; Carcinoma; Disseminated Intravascular | 1992 |